# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001827506-25-000048
Filing Date
2025-04-21
Accepted
2025-04-21 16:09:39
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | a04212025defa14a.htm | DEFA14A | 10177
2 |  | trml2025noticepage1.jpg | GRAPHIC | 2371982
3 |  | trml2025noticepage2.jpg | GRAPHIC | 75300
| Complete submission text file | 0001827506-25-000048.txt |  | 3376078

Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40384 | Film No.: 25853226
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)